OrthoPediatrics/$KIDS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About OrthoPediatrics
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Ticker
$KIDS
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
562
ISIN
US68752L1008
Website
OrthoPediatrics Metrics
BasicAdvanced
$546M
-
-$1.76
1.10
-
Price and volume
Market cap
$546M
Beta
1.1
52-week high
$35.99
52-week low
$19.52
Average daily volume
144K
Financial strength
Current ratio
6.187
Quick ratio
2.74
Long term debt to equity
22.964
Total debt to equity
23.01
Interest coverage (TTM)
-9.88%
Profitability
EBITDA (TTM)
-11.639
Gross margin (TTM)
72.81%
Net profit margin (TTM)
-19.15%
Operating margin (TTM)
-14.47%
Effective tax rate (TTM)
3.28%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
-4.23%
Return on equity (TTM)
-11.33%
Valuation
Price to revenue (TTM)
2.407
Price to book
1.58
Price to tangible book (TTM)
3.14
Price to free cash flow (TTM)
-13.993
Free cash flow yield (TTM)
-7.15%
Free cash flow per share (TTM)
-157.65%
Growth
Revenue change (TTM)
31.28%
Earnings per share change (TTM)
82.16%
3-year revenue growth (CAGR)
28.55%
3-year earnings per share growth (CAGR)
31.37%
What the Analysts think about OrthoPediatrics
Analyst ratings (Buy, Hold, Sell) for OrthoPediatrics stock.
Bulls say / Bears say
OrthoPediatrics reported record revenue of $205 million in 2024, marking a 38% year-over-year growth, indicating strong market demand for its pediatric orthopedic products. (nasdaq.com)
The company expanded its product portfolio with the launch of the 3P™ Pediatric Plating Platform™ Hip System, enhancing its offerings in trauma and deformity correction. (stocktitan.net)
Analysts at Lake Street Capital initiated coverage with a 'buy' rating and a $37 price target, suggesting a potential upside of approximately 74.86% from the current stock price. (marketbeat.com)
OrthoPediatrics' stock reached a 52-week low of $20.26 on April 17, 2025, reflecting investor concerns amid market challenges. (investing.com)
The company reported a Q4 2024 loss of $0.29 per share, missing revenue estimates and indicating potential operational challenges. (nasdaq.com)
Analysts at Truist Financial decreased their price target for OrthoPediatrics from $28.00 to $25.00, assigning a 'hold' rating, suggesting limited short-term growth prospects. (marketbeat.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.
OrthoPediatrics Financial Performance
Revenues and expenses
OrthoPediatrics Earnings Performance
Company profitability
OrthoPediatrics News
AllArticlesVideos
OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting
GlobeNewsWire·2 months ago
OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
GlobeNewsWire·2 months ago
OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for OrthoPediatrics stock?
OrthoPediatrics (KIDS) has a market cap of $546M as of July 10, 2025.
What is the P/E ratio for OrthoPediatrics stock?
The price to earnings (P/E) ratio for OrthoPediatrics (KIDS) stock is 0 as of July 10, 2025.
Does OrthoPediatrics stock pay dividends?
No, OrthoPediatrics (KIDS) stock does not pay dividends to its shareholders as of July 10, 2025.
When is the next OrthoPediatrics dividend payment date?
OrthoPediatrics (KIDS) stock does not pay dividends to its shareholders.
What is the beta indicator for OrthoPediatrics?
OrthoPediatrics (KIDS) has a beta rating of 1.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.